HydRegen raises £2.6 million to clean up the chemical manufacturing and pharmaceutical industries
HydRegen, the Oxford-based biotechnology company enabling sustainable chemical manufacturing, has secured a £2.6 million investment as part of its latest fundraise, led by Clean Growth Fund, the UK clean-tech venture capital fund.
The new investment from Clean Growth Fund, alongside a group of existing investors, will support the commercial development and deployment of HydRegen’s technologies through the next 18 months. HydRegen plans to license its technology to companies manufacturing pharmaceutical and chemical products around the world. To do this, it also plans to expand its team over the next 12 months.